These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
265 related items for PubMed ID: 9045892
1. Contiguous four-guanosine sequence in c-myc antisense phosphorothioate oligonucleotides inhibits cell growth on human lung cancer cells: possible involvement of cell adhesion inhibition. Saijo Y, Uchiyama B, Abe T, Satoh K, Nukiwa T. Jpn J Cancer Res; 1997 Jan; 88(1):26-33. PubMed ID: 9045892 [Abstract] [Full Text] [Related]
2. Contribution of sequence and phosphorothioate content to inhibition of cell growth and adhesion caused by c-myc antisense oligomers. Chavany C, Connell Y, Neckers L. Mol Pharmacol; 1995 Oct; 48(4):738-46. PubMed ID: 7476902 [Abstract] [Full Text] [Related]
3. Inhibition of c-myc expression by phosphorothioate antisense oligonucleotide identifies a critical role for c-myc in the growth of human breast cancer. Watson PH, Pon RT, Shiu RP. Cancer Res; 1991 Aug 01; 51(15):3996-4000. PubMed ID: 1855215 [Abstract] [Full Text] [Related]
4. Antiproliferative effect of c-myc antisense phosphorothioate oligodeoxynucleotides in malignant glioma cells. Broaddus WC, Chen ZJ, Prabhu SS, Loudon WG, Gillies GT, Phillips LL, Fillmore H. Neurosurgery; 1997 Oct 01; 41(4):908-15. PubMed ID: 9316053 [Abstract] [Full Text] [Related]
5. A combination treatment of c-myc antisense DNA with all-trans-retinoic acid inhibits cell proliferation by downregulating c-myc expression in small cell lung cancer. Akie K, Dosaka-Akita H, Murakami A, Kawakami Y. Antisense Nucleic Acid Drug Dev; 2000 Aug 01; 10(4):243-9. PubMed ID: 10984118 [Abstract] [Full Text] [Related]
6. Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice. Leonetti C, D'Agnano I, Lozupone F, Valentini A, Geiser T, Zon G, Calabretta B, Citro G C, Zupi G. J Natl Cancer Inst; 1996 Apr 03; 88(7):419-29. PubMed ID: 8618233 [Abstract] [Full Text] [Related]
7. Inhibition of cell adhesion to plastic substratum by phosphorothioate oligonucleotide. Watson PH, Pon RT, Shiu RP. Exp Cell Res; 1992 Oct 03; 202(2):391-7. PubMed ID: 1397092 [Abstract] [Full Text] [Related]
8. The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism. Burgess TL, Fisher EF, Ross SL, Bready JV, Qian YX, Bayewitch LA, Cohen AM, Herrera CJ, Hu SS, Kramer TB. Proc Natl Acad Sci U S A; 1995 Apr 25; 92(9):4051-5. PubMed ID: 7732029 [Abstract] [Full Text] [Related]
9. Inhibition of the proliferative effect of transforming growth factor-alpha by c-myc antisense DNA in human ovarian cancer cells. Park HY. Biochem Mol Biol Int; 1997 Dec 25; 43(5):1015-22. PubMed ID: 9415810 [Abstract] [Full Text] [Related]
10. Inhibition of protein kinase C-alpha expression in human A549 cells by antisense oligonucleotides inhibits induction of intercellular adhesion molecule 1 (ICAM-1) mRNA by phorbol esters. Dean NM, McKay R, Condon TP, Bennett CF. J Biol Chem; 1994 Jun 10; 269(23):16416-24. PubMed ID: 7911467 [Abstract] [Full Text] [Related]
11. Phosphorothioate BCR-ABL antisense oligonucleotides induce cell death, but fail to reduce cellular bcr-abl protein levels. Smetsers TF, van de Locht LT, Pennings AH, Wessels HM, de Witte TM, Mensink EJ. Leukemia; 1995 Jan 10; 9(1):118-30. PubMed ID: 7845006 [Abstract] [Full Text] [Related]
12. Quantifying c-myc expression in c-myc antisense phosphorothioate oligodeoxynucleotide-treated leukemic and colon cancer cell lines. Li BD, Budnick RM, Russo CA, Anderson GR, Stewart CC. J Surg Res; 1995 Oct 10; 59(4):485-92. PubMed ID: 7564322 [Abstract] [Full Text] [Related]
13. Phosphorothioated antisense c-myc oligonucleotide inhibits the growth of human colon carcinoma cells. Yu BW, Nguyen D, Anderson S, Allegra CA. Anticancer Res; 1997 Oct 10; 17(6D):4407-13. PubMed ID: 9494542 [Abstract] [Full Text] [Related]
14. Antiproliferative effects of a c-myc antisense oligonucleotide on human arterial smooth muscle cells. Ebbecke M, Unterberg C, Buchwald A, Stöhr S, Wiegand V. Basic Res Cardiol; 1992 Oct 10; 87(6):585-91. PubMed ID: 1485890 [Abstract] [Full Text] [Related]
15. Antisense c-myc and immunostimulatory oligonucleotide inhibition of tumorigenesis in a murine B-cell lymphoma transplant model. Smith JB, Wickstrom E. J Natl Cancer Inst; 1998 Aug 05; 90(15):1146-54. PubMed ID: 9701364 [Abstract] [Full Text] [Related]
16. Antisense c-myc effects on preimplantation mouse embryo development. Paria BC, Dey SK, Andrews GK. Proc Natl Acad Sci U S A; 1992 Nov 01; 89(21):10051-5. PubMed ID: 1279668 [Abstract] [Full Text] [Related]
17. Downregulation of c-myc expression by antisense oligonucleotides inhibits proliferation of human smooth muscle cells. Shi Y, Hutchinson HG, Hall DJ, Zalewski A. Circulation; 1993 Sep 01; 88(3):1190-5. PubMed ID: 8353880 [Abstract] [Full Text] [Related]
18. Antiproliferative effects of antisense oligonucleotides directed to the RNA of c-myc oncogene. Degols G, Leonetti JP, Mechti N, Lebleu B. Nucleic Acids Res; 1991 Feb 25; 19(4):945-8. PubMed ID: 1708128 [Abstract] [Full Text] [Related]
19. Antisense inhibitory effect: a comparison between 3'-partial and full phosphorothioate antisense oligonucleotides. Galderisi U, Di Bernardo G, Melone MA, Galano G, Cascino A, Giordano A, Cipollaro M. J Cell Biochem; 1999 Jul 01; 74(1):31-7. PubMed ID: 10381259 [Abstract] [Full Text] [Related]
20. Reduction of cisplatin cytotoxicity on human lung cancer cell lines with N-myc amplification by pretreatment with N-myc antisense oligodeoxynucleotides. Mizushima Y, Kashii T, Kobayashi M. Anticancer Res; 1995 Jul 01; 15(1):37-43. PubMed ID: 7733638 [Abstract] [Full Text] [Related] Page: [Next] [New Search]